Haematological Malignancy Diagnostics
Bristol Haemato-Oncology Diagnostic Service (BHODS)
The Bristol Haemato-Oncology Diagnostic Service was developed to provide an integrated diagnostic process for investigation and reporting blood, bone marrow, lymph node and other tissue samples investigated for the presence of haematological malignancy. The service satisfies the NICE improving outcomes guidance published in 2004.
The integrated diagnostic service is supported by haematologists and haematopathologists using the HiLIS and GEC Ultra laboratory software system to correlate investigation into an integrated report. A diagnostic opinion is given based upon the current WHO classification of haematological malignancies and SNOMED codes are provided.
Techniques include the following: Flow Cytometry, Histopathology, Cytogenetics, Fluorescence in-situ hybridisation (FISH), Molecular Genetics.